Arvinas is continuing its investigation of arv-102 in neurodegenerative diseases associated with lrrk2 and lysosome ...

Archie Wilson and Rory Hanna, the founders of London-based business start-up and pet health supplement company, PAWD DRINKS, ...

Arvinas (ARVN) presented data from the first-in-human clinical trial of ARV-102, the Company’s investigational PROteolysis TArgeting Chimera ...

Researchers suggest results could reignite interest in DLK inhibition as a treatment strategy for neurodegenerative diseases.

Innovstone Therapeutics Ltd. has synthesized leucine-rich repeat kinase 2 (LRRK2; Dardarin) inhibitors reported to be useful for the treatment of Parkinson’s disease.

SARMs can lower natural testosterone levels, so a recovery phase may be needed after the cycle. For LGD-4033, the effect on ...

Rising Utilization in Pharmaceutical Industry The pharmaceutical sector is increasingly leveraging amino acids in drug ...

Neurodegenerative conditions such as Parkinson's disease and Alzheimer's involve progressive neuronal loss due to disease-induced damage. An enzyme ...

Neurodegenerative conditions such as Parkinson's disease and Alzheimer's involve progressive neuronal loss due to ...

By influencing calcium homeostasis, local protein synthesis and the endoplasmic reticulum, a small protein called Rab10 emerges as a crucial cytoplasmic regulator of neuropeptide secretion.

CarePal, the parent company of Impact Guru, in its State of Cancer Fundraising Report 2024, revealed that the top 100 cancer ...

Kolkata: Doctors have warned against indiscriminate consumption of whey proteins from an early age by gym-going teens and ...